International Association of
Therapeutic Drug Monitoring and Clinical Toxicology
Fostering education, research and practice in TDM and CT

Interview with Bianca Maria Goffredo

This month we hear from Bianca Maria Goffredo from the Laboratory of Metabolic Pathology at Bambino Gesù Children's Hospital in Rome. Bianca shares about her experience in developing drug assays and applying them to personalize therapy, especially for pediatric patients.


Bianca Maria Goffredo
Laboratory of Metabolic Pathology
Bambino Gesù Children's Hospital, Rome, Italy

Interview with Sara Baldelli

Sara Baldelli

This month we hear from Sara Baldelli from the Unit of Clinical Pharmacology, Luigi Sacco University Hospital in Milan. Sara shares about the achievements of the lab, where they have come a long way since opening 10 years ago. I was especially interested to hear about the Quality by Design (QbD), a concept applied to developing new analytical methods. For the future, Sara has her eye on emerging variants of ambient ionization mass spectrometry that may enable direct measurements in tissues and organs.


Sara Baldelli
Unit of Clinical Pharmacology
Luigi Sacco University Hospital, Milan, Italy

Interview with Giuliana Cangemi

Giuliana Cangemi

This month we hear from Giuliana Cangemi, head of the Chromatography and Mass Spectrometry Section of the Central Laboratory of Analyses of the Giannina Gaslini Institute. The institute is a pediatric hospital with modest beginnings in the 1930s, but that is now a very large and very impressive teaching hospital. Providing a clinical service as well as undertaking research means that Giuliana and her colleagues work in a very integrated way that truly serves translational science. I loved reading that Giuliana considers teamwork as the most innovative part of what they do at the department! Read on!


Giuliana Cangemi
Chromatography and Mass Spectrometry Section, Central Laboratory of Analyses
IRCCS Istituto Giannina Gaslini, Genoa, Italy

Interview with Antonio D'Avolio

Antonio D'Avolio

In the months leading up to our conference in Rome we are excited to be profiling Italian Scientists. This month we hear from Professor Antonio D'Avolio from Amedeo di Savoia Hospital, Turin, a centre known for their pioneering work in personalizing HIV therapy. More recently, this group was among the first to work with remdesivir and determining concentration in the critically ill COVID patient. We are very grateful to Professor D'Avolio for sharing his experiences. Read on!


Antonio D'Avolio
Professor of Pharmacology
Head of the Laboratory of Clinical Pharmacology and Pharmacogenetics
University of Turin, Amedeo di Savoia Hospital, Turin, Italy

Page 4 of 22

The content of the IATDMCT Blog does not necessarily have the endorsement of the Association.